Markets

Cellyan Biotechnology Announces 1-For-20 Reverse Stock Split, Effective Oct. 26

Oct 21, 2026 · 08:01 AM ET· updated 1h ago

Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over-the-counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, announced that it

Why It Matters

Cellyan is combining every 20 old shares into 1 new share. When a company does this, watch if the business is actually getting stronger or just rearranging numbers.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

HKPD0.09

-0.03 (-24.11%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.